Healthcare provider profile · identity verified

Yul Ejnes, MD

Internal Medicine · CRANSTON, RI · NPI 1679568802

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1303	364
Lisinopril	Lisinopril	680	198
Omeprazole	Omeprazole	569	161
Amlodipine Besylate	Amlodipine Besylate	539	165
Losartan Potassium	Losartan Potassium	509	159
Levothyroxine Sodium	Levothyroxine Sodium	373	109
Hydrochlorothiazide	Hydrochlorothiazide	349	113
Fluticasone Propionate	Fluticasone Propionate	297	127
Metoprolol Succinate	Metoprolol Succinate	245	66
Atenolol	Atenolol	225	71
Metformin Hcl Er	Metformin Hcl	208	65
Eliquis	Apixaban	198	39
Simvastatin	Simvastatin	188	59
Sertraline Hcl	Sertraline Hcl	182	48
Trazodone Hcl	Trazodone Hcl	179	59
Rosuvastatin Calcium	Rosuvastatin Calcium	178	58
Alendronate Sodium	Alendronate Sodium	174	49
Pantoprazole Sodium	Pantoprazole Sodium	161	49
Jardiance	Empagliflozin	159	27
Pravastatin Sodium	Pravastatin Sodium	151	46
Tamsulosin Hcl	Tamsulosin Hcl	148	46
Metformin Hcl	Metformin Hcl	146	44
Lorazepam	Lorazepam	145	48
Gabapentin	Gabapentin	142	39
Metoprolol Tartrate	Metoprolol Tartrate	142	43
Albuterol Sulfate Hfa	Albuterol Sulfate	134	48
Ozempic	Semaglutide	133	20
Furosemide	Furosemide	126	46
Allopurinol	Allopurinol	117	31
Famotidine	Famotidine	113	33
Citalopram Hbr	Citalopram Hydrobromide	111	31
Meloxicam	Meloxicam	96	28
Escitalopram Oxalate	Escitalopram Oxalate	94	28
Alprazolam	Alprazolam	86	24
Montelukast Sodium	Montelukast Sodium	84	22
Clonazepam	Clonazepam	82	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	17
Paroxetine Hcl	Paroxetine Hcl	82	23
Zolpidem Tartrate	Zolpidem Tartrate	81	19
Mirtazapine	Mirtazapine	79	14
Potassium Chloride	Potassium Chloride	74	22
Tramadol Hcl	Tramadol Hcl	72	14
Valsartan	Valsartan	70	22
Duloxetine Hcl	Duloxetine Hcl	64	20
Xarelto	Rivaroxaban	62	15
Ibuprofen	Ibuprofen	60	20
Glipizide Er	Glipizide	58	16
Azelastine Hcl	Azelastine Hcl	53	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	12
Ezetimibe	Ezetimibe	51	16
Fluoxetine Hcl	Fluoxetine Hcl	50	13
Wixela Inhub	Fluticasone Propion/Salmeterol	49	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	46	suppressed
Bupropion Xl	Bupropion Hcl	45	19
Clopidogrel	Clopidogrel Bisulfate	45	14
Doxazosin Mesylate	Doxazosin Mesylate	45	13
Spironolactone	Spironolactone	43	12
Triamcinolone Acetonide	Triamcinolone Acetonide	43	20
Felodipine Er	Felodipine	42	13
Finasteride	Finasteride	42	13
Warfarin Sodium	Warfarin Sodium	41	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	40	suppressed
Januvia	Sitagliptin Phosphate	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Trulicity	Dulaglutide	39	suppressed
Pregabalin	Pregabalin	38	suppressed
Donepezil Hcl	Donepezil Hcl	37	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	12
Prednisone	Prednisone	37	18
Amitriptyline Hcl	Amitriptyline Hcl	34	12
Diclofenac Sodium	Diclofenac Sodium	34	suppressed
Telmisartan	Telmisartan	34	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	11
Diazepam	Diazepam	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Ipratropium Bromide	Ipratropium Bromide	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Nystatin	Nystatin	27	15
Paxlovid	Nirmatrelvir/Ritonavir	26	26
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Dexlansoprazole Dr	Dexlansoprazole	20	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Naproxen	Naproxen	20	suppressed
Rybelsus	Semaglutide	20	suppressed
Irbesartan	Irbesartan	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Dulera	Mometasone/Formoterol	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Wegovy	Semaglutide	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Carvedilol	Carvedilol	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Tiadylt Er	Diltiazem Hcl	16	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Percocet	Oxycodone Hcl/Acetaminophen	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Glipizide	Glipizide	14	suppressed
Nadolol	Nadolol	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Indapamide	Indapamide	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Colchicine	Colchicine	12	suppressed
Cymbalta	Duloxetine Hcl	12	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	12	suppressed
Estradiol	Estradiol	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Tivicay	Dolutegravir Sodium	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Fosinopril Sodium	Fosinopril Sodium	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed
Tramadol Hcl Er	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error